DO ONCOGENES DETERMINE CLINICAL FEATURES IN CHRONIC MYELOID LEUKAEMIA?
References (21)
- et al.
Chromosome abnormalities in malignant hematologic diseases
Adv Cancer Res
(1982) - et al.
Rearrangement of the bcr gene in Philadelphia chromosome negative chronic myeloid leukemia
Blood
(1986) - et al.
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Cell
(1986) - et al.
Chronic leukemias: oncogenes, chromosomes and advances in therapy
Ann Intern Med
(1986) - et al.
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated protein tyrosine kinase activity
Cell
(1984) - et al.
Chronic granulocytic leukemias without the Philadelphia chromosome
Am J Clin Pathol
(1976) - et al.
Philadelphia chromosome positive and negative chronic myeloid leukemia
Ann Intern Med
(1970) - et al.
Philadelphia-chromosome negative chronic myelogenous leukaemia: a morphological reassessment
Br J Haematol
(1985) - et al.
Ph-negative chronic granulocytic leukemia: a nonentity
Am J Clin Pathol
(1986) - et al.
Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia
Cancer
(1986)
There are more references available in the full text version of this article.
Cited by (56)
Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia
1996, Cancer Genetics and CytogeneticsThe role of the BCR/ABL oncogene in human leukemia
1995, Advances in Genome BiologyComplex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis
1994, Cancer Genetics and Cytogenetics
Copyright © 1987 Published by Elsevier Ltd.